Retraction: Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer (International Journal of Molecular Medicine (2015) 36 (204-214) DOI: 10.3892/ijmm.2015.2217);Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer

International Journal of Molecular Medicine

Volumn 36, Issue 1, 2015, Pages 204-214

  Fan, Cong ^a   Wang, Yunshan ^b,c   Liu, Ziming ^d   Sun, Ying ^a   Wang, Xiuwen ^a   Wei, Guangwei ^b   Wei, Junmin ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANDONG UNIVERSITY   (China)

^d The Fifth People's Hospital of Jinan   (China)

Author keywords

AMP activated protein kinase; Breast cancer; Cancer stem cells; Metformin; Sonic hedgehog signaling pathway

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; SMALL INTERFERING RNA; SONIC HEDGEHOG PROTEIN; ANTINEOPLASTIC AGENT; CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLI1 PROTEIN, HUMAN; PRKAG1 PROTEIN, HUMAN; PROTEIN PATCHED; SHH PROTEIN, HUMAN; SMO PROTEIN, HUMAN; SMOOTHENED PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GLI1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL RENEWAL; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BREAST NEOPLASMS; CANCER STEM CELL; CELL MOTION; DRUG EFFECTS; DRUG SCREENING; GENETICS; MCF-7 CELL LINE; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; TUMOR CELL CULTURE; TUMOR INVASION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HEDGEHOG PROTEINS; HUMANS; MCF-7 CELLS; METFORMIN; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PATCHED RECEPTORS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMOOTHENED RECEPTOR; SPHEROIDS, CELLULAR; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS; ZINC FINGER PROTEIN GLI1;

EID: 84930320110     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2023.5227     Document Type: Erratum

References (35)

1. Alexander GC, Sehgal NL, Moloney RM and Stafford RS: National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med 168: 2088-2094, 2008.
2. Bosco JL, Antonsen S, Sørensen HT, Pedersen L and Lash TL: Metformin and incident breast cancer among diabetic women: A population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev 20: 101-111, 2011.
3. Kisfalvi K, Eibl G, Sinnett-Smith J and Rozengurt E: Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res 69: 6539-6545, 2009.
4. Hosono K, Endo H, Takahashi H, Sugiyama M, Sakai E, Uchiyama T, Suzuki K, Iida H, Sakamoto Y, Yoneda K, et al: Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prev Res (Phila) 3: 1077-1083, 2010.
5. Azoulay L, Dell'Aniello S, Gagnon B, Pollak M and Suissa S: Metformin and the incidence of prostate cancer in patients with type 2 diabetes. Cancer Epidemiol Biomarkers Prev 20: 337-344, 2011.
6. Ben Sahra I, Laurent K, Loubat A, Giorgetti-Peraldi S, Colosetti P, Auberger P, Tanti JF, Le Marchand-Brustel Y and Bost F: The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 27: 3576-3586, 2008.
7. Hirsch HA, Iliopoulos D, Tsichlis PN and Struhl K: Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69: 7507-7511, 2009.
8. Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinis RJ, Zhao F, Viollet B and Thompson CB: Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 67: 6745-6752, 2007.
9. Shackelford DB and Shaw RJ: The LKB1-AMPK pathway: Metabolism and growth control in tumour suppression. Nat Rev Cancer 9: 563-575, 2009.
10. Zheng L, Yang W, Wu F, Wang C, Yu L, Tang L, Qiu B, Li Y, Guo L, Wu M, et al: Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma. Clin Cancer Res 19: 5372-5380, 2013.
11. Kahn BB, Alquier T, Carling D and Hardie DG: AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25, 2005.
12. Rocha GZ, Dias MM, Ropelle ER, Osório-Costa F, Rossato FA, Vercesi AE, Saad MJ and Carvalheira JB: Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth. Clin Cancer Res 17: 3993-4005, 2011.
13. Dowling RJ, Zakikhani M, Fantus IG, Pollak M and Sonenberg N: Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res 67: 10804-10812, 2007.
14. Ingham PW and McMahon AP: Hedgehog signaling in animal development: Paradigms and principles. Genes Dev 15: 3059-3087, 2001.
15. Varjosalo M and Taipale J: Hedgehog: Functions and mechanisms. Genes Dev 22: 2454-2472, 2008.
16. Zhu AJ, Zheng L, Suyama K and Scott MP: Altered localization of Drosophila Smoothened protein activates Hedgehog signal transduction. Genes Dev 17: 1240-1252, 2003.
17. Murone M, Rosenthal A and de Sauvage FJ: Hedgehog signal transduction: From flies to vertebrates. Exp Cell Res 253: 25-33, 1999.
18. Kubo M, Nakamura M, Tasaki A, Yamanaka N, Nakashima H, Nomura M, Kuroki S and Katano M: Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res 64: 6071-6074, 2004.
19. Onishi H and Katano M: Hedgehog signaling pathway as a therapeutic target in various types of cancer. Cancer Sci 102: 1756-1760, 2011.
20. Jeng KS, Sheen IS, Jeng WJ, Yu MC, Hsiau HI and Chang FY: High expression of Sonic Hedgehog signaling pathway genes indicates a risk of recurrence of breast carcinoma. Onco Targets Ther 7: 79-86, 2013.
21. Nakamura M, Ogo A, Yamura M, Yamaguchi Y and Nakashima H: Metformin suppresses sonic hedgehog expression in pancreatic cancer cells. Anticancer Res 34: 1765-1769, 2014.
22. Visvader JE: Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 23: 2563-2577, 2009.
23. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270, 2003.
24. Bombonati A and Sgroi DC: The molecular pathology of breast cancer progression. J Pathol 223: 307-317, 2011.
25. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003.
26. O'Brien CA, Kreso A and Jamieson CH: Cancer stem cells and self-renewal. Clin Cancer Res 16: 3113-3120, 2010.
27. Ailles LE and Weissman IL: Cancer stem cells in solid tumors. Curr Opin Biotechnol 18: 460-466, 2007.
28. Kakarala M and Wicha MS: Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 26: 2813-2820, 2008.
29. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA and Lander ES: Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645-659, 2009.
30. Rattan R, Graham RP, Maguire JL, Giri S and Shridhar V: Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. Neoplasia 13: 483-491, 2011.
31. Rattan R, Giri S, Hartmann LC and Shridhar V: Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. J Cell Mol Med 15: 166-178, 2011.
32. Bodmer M, Meier C, Krähenbühl S, Jick SS and Meier CR: Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33: 1304-1308, 2010.
33. Zakikhani M, Dowling R, Fantus IG, Sonenberg N and Pollak M: Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 66: 10269-10273, 2006.
34. Janzer A, German NJ, Gonzalez-Herrera KN, Asara JM, Haigis MC and Struhl K: Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells. Proc Natl Acad Sci USA 111: 10574-10579, 2014.
35. Ramaswamy B, Lu Y, Teng KY, Nuovo G, Li X, Shapiro CL and Majumder S: Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway. Cancer Res 72: 5048-5059, 2012.